Ordinary Adjustment | Solactive Diabetes Performance-Index | March 2019

In the ordinary index rebalance, the following composition will be implemented:

ABBOTT LABORATORIES
CONVATEC GROUP PLC
DEXCOM INC
KALVISTA PHARMACEUTICALS INC
ELI LILLY & CO
LEXICON PHARMACEUTICALS INC
MANNKIND CORP
NOVO NORDISK AS CLASS B
INSULET CORP
POXEL SA
SENSEONICS HOLDINGS INC
TANDEM DIABETES CARE INC
YPSOMED HOLDING AG
ZEALAND PHARMA A/S